Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. LLY
LLY logo

LLY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY News

Eli Lilly's Foundayo Prescription Growth Amidst Market Competition

1d agoseekingalpha

Eli Lilly's Foundayo Prescription Analysis

1d agoNewsfilter

Can Eli Lilly Reclaim a $1 Trillion Market Cap?

1d agoFool

Eli Lilly Aims to Reinstate Market Leadership Amid Competitive Landscape

1d agoNASDAQ.COM

Overview of This Week's Dividend Activities

1d agoseekingalpha

Doceree Launches New System for Pharma Brand Teams

1d agoYahoo Finance

First Generic Versions of Ozempic Approved in Canada

2d agoNewsfilter

Eli Lilly's Stock Surge and Competitor Analysis

2d agoFool

Eli Lilly's Mounjaro Becomes World's Best-Selling Drug

2d agoFool

Weight-Loss Pills Boost Novo Nordisk and Eli Lilly Shares

2d agoNewsfilter

Eli Lilly's Dominance in the Anti-Obesity Drug Market

2d agoFool

Eli Lilly Reports 56% Revenue Surge in Q1 2026

2d agoYahoo Finance

ELI LILLY SUBMITS SEC FILING FOR EIGHT-PART NOTES OFFERING WORTH UP TO $9 BILLION

2d agomoomoo

Eli Lilly Invests $4.5 Billion in Indiana for Advanced Therapies

3d agostocktwits

Novo Nordisk CEO: Seeking More Deals to Broaden Pipeline

3d agoCNBC

Novo Nordisk Actively Pursuing Acquisition Opportunities

3d agoNewsfilter